Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-115 manufacturers

Filters

None products found

pp-115

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
China
Comments
Indication: Solid tumors (exact tumor types not fully disclosed), targeting patients with advanced or metastatic disease Clinical stage: Early clinical development (Phase 1) Modality: Small molecule Mechanism / Target: Not fully disclosed; described as a targeted anticancer agent with novel mechanism under investigation Route / form: Oral (likely tablet/capsule based on small molecule oncology pipeline standards) Differentiation: Early-stage targeted therapy with potential for novel mechanism; positioning likely focused on differentiated efficacy or safety in defined molecular subpopulations, though biomarker strategy not yet publicly detailed
Manufacturer #39090

Clinical-stage pharmaceutical company focused on oncology, neuroscience, and autoimmune diseases. Develops innovative and generic medicines with growing global ambitions. Strategy includes partnerships and selective international expansion.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.